It's hard to believe today, but there was a time when Boeing stock sold for more than $400 a share. That's more than double its current value.
I remember those days, though, because Boeing was a recommendation of mine back in 2018. That's when I officially began covering defense stocks.
Boeing was a surefire pick back then. It was a company with a strong, even fabled track record stretching back to 1916.
And six years ago, it was living up to its name. By 2019, I was sitting on a 50% gain in just about a year's time. That's when tragedy struck.
Just over five years ago, 346 people died in two separate plane crashes five months apart. One was in Indonesia and the other Ethiopia. Both planes were Boeing 737 Max 8s.
The first crash seemed like a fluke, as any plane crash does these days. But when the second one went down, it was clear something was off at Boeing.
Still, the company's track record and reputation shielded it from a total collapse. Its stock continued to cruise around $350–$375 per share until the pandemic hit in 2020.
You obviously can't blame the company for that. The COVID pandemic was unlike anything we've ever experienced. Air travel was obviously a no-go and commercial jet companies like Boeing never stood a chance.
Nevertheless, the world moved on and the global economy (and the U.S. economy, in particular) recovered. Boeing stock rebounded as a result, and it looked as though the company was ready to resume its ascendance back to an elite level.
See this tiny pill?
This is a brand new class of medicine that could make you an absolute FORTUNE.
Now, this isn't Ozempic...
It's called EN-23, and it's turning traditional medicine on its head.
Because instead of addressing and treating only one issue at a time like diabetes or obesity...
EN-23 could treat both along with an almost LIMITLESS number of diseases with 60-100% effectiveness with just a single dose!
At this very moment, scientists around the world are studying EN-23 for the treatment of:
- Alzheimer's disease...
- Parkingson's disease...
- Arthritis...
- Diabetes...
- Erectile dysfunction...
- Obesity...
- Epilepsy...
- Autoimmune diseases...
- Chronic pain...
- Insomnia...
- PTSD...
- And many more!
Just on these eleven conditions alone, you're looking at more than $1 Trillion up for grabs.
That's why Kevin O'Leary, Peter Thiel, and CEO of ChatGPT, Sam Altman have all invested in EN-23...
And they're all betting big money that EN-23 will be far more profitable than Ozempic!
After all, EN-23 is about to swipe market share from some of the most profitable disease treatments in the world...
And there are currently three EN-23 companies in particular that stand to get a sizable chunk of this action.
That's why savvy investors who act right now have the chance to grab a slice of a $1 Trillion windfall.
Learn more about this life-saving treatment here.
Of course, that's not what happened. Instead, labor disputes and cost-cutting decisions Boeing made at the height of the pandemic came back to bite the company in a big way.
Some 7,500 engineers and machinists were laid off in 2020. And it's hard to believe that doesn't in some way explain Boeing's more recent mishaps.
In January, a fatal catastrophe was barely avoided when a door plug blew off a 737 Max 9 plane at 16,000 feet just as it took off from Portland, Oregon. A preliminary report from U.S. accident investigators said the door panel was missing four key bolts.
Worse, after the plane was grounded, Alaska Airlines conducted a review of its entire Boeing fleet and found that loose bolts were disturbingly abundant. And now, the Department of Justice is now investigating the incident to see if a crime was committed.
"Boeing is better than this," said Alaska CEO Ben Minicucci. "Flight 1282 should never have happened."
Nvidia Could Crash Soon
Nvidia's days are numbered...
Because there's a new player in the AI market...
A Californian company that developed a groundbreaking chip — one that outperforms Nvidia's chips 100x.
The U.S. Air Force is just one elite client that was allowed to use it early.
But soon this chip will be available to the mainstream.
And if you position yourself before it reaches the mass market, you could turn every $1 into $120...
Just like early Nvidia investors did.
Keith Kohl just published an urgent presentation on this unique opportunity.
Get the full story here while there's still time.
Well, he's right that Flight 1282 never should have happened… but is Boeing really better than this?
Apparently not. Because just this week, a Houston-bound Boeing 737-800 plane made an emergency stop in Denver when an engine cover fell off and struck the plane's wing flap.
Ladies and gentlemen, I flew to Florida and back to Baltimore last week. Both trips were on a Boeing 737. And yes, I felt compelled to stare out the window looking for flying nuts and loose panels.
I had to tune out the children screaming behind me so I could listen for any out-of-place rattling sounds. This is how I will spend every flight on a Boeing from here to eternity — nervously scouring the fuselage for any imperfections.
It's not just me, either. Boeing has turned millions of air travelers into nervous wrecks. And the fact that its CEO has agreed to step down at the end of the year does nothing to assuage that.
Dave Calhoun will be replaced, but not with a new coterie of engineers, mechanics, and quality control personnel. He'll be replaced with another executive whose only real concern is the value of his stock options.
Along with valuable business and the workers that make it all happen, another thing that disappeared in 2020 was Boeing's dividend. There's no reason to believe that will return any time soon either.
Boeing is toast. It simply can't be trusted — not by passengers and certainly not by investors.
So if you want to invest in flight technology, invest in drones. Specifically, drones made by companies like this one.
Fight on,
Jason Simpkins
Gold Prices Just Reached ANOTHER All-Time High
(Screaming BUY ALERT on This $1 stock)
At over $2,270 per ounce, gold prices just reached a NEW record high.
Driven by expectations of U.S. interest rate cuts...
And a surge in demand due to the poor performance in China's real estate sector...
Gold is poised to shatter numerous records in the coming weeks alone.
But I'm not buying gold bars anytime soon...
Instead, I'm directing my readers to a high-grade discovery that could dominate headlines in 2024.
Recent drilling results from a five-mile stretch in rural North America have legendary precious metals investor Eric Sprott calling it "one of the greatest gold discoveries in history."
Buried at remarkably shallow depths are 1.6 million ounces of high-grade gold ore valued at $2.4 billion...
A figure that's about to go nuclear as Big Tech's demand for gold far exceeds the supply.
The best part? Shares of the company controlling this land are currently valued at under $1 — but not for long.
Buying shares now could yield an impressive 57x return on your investment...
Transforming every $10,000 invested into over $500,000!
Act quickly on this urgent gold opportunity while you still can.
Tidak ada komentar:
Posting Komentar